The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of RX-3117, an oral antimetabolite nucleoside, in combination with nab-paclitaxel (nab-pac) as first-line treatment of metastatic pancreatic cancer (met-PC): Preliminary results.
 
Hani M. Babiker
Consulting or Advisory Role - Celgene; Endocyte
 
Peter J. Schlegel
No Relationships to Disclose
 
Lee G. Hicks
No Relationships to Disclose
 
Andrea J. Bullock
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Medtronic
Consulting or Advisory Role - Bayer; Celgene; Exelixis; Halozyme; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Halozyme
 
Nafisa Burhani
No Relationships to Disclose
 
Ely Benaim
Employment - Rexahn Pharmaceuticals
Leadership - Rexahn Pharmaceuticals
Stock and Other Ownership Interests - Rexahn Pharmaceuticals
Honoraria - Rexahn Pharmaceuticals
 
Christine Peterson
Employment - Rexahn Pharmaceuticals
Stock and Other Ownership Interests - Rexahn Pharmaceuticals
 
Callie Heaton
No Relationships to Disclose
 
Allyson J. Ocean
No Relationships to Disclose